These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3311778)

  • 1. A follow-up study of cell-mediated cytotoxicity and beta cell function in type I diabetes.
    Bierwolf B; Verlohren HJ; Lohmann D; Lampeter EF; Krug J
    Exp Clin Endocrinol; 1987 Aug; 89(3):363-7. PubMed ID: 3311778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immune reactions against islets of Langerhans in diabetes-prone BB rats.
    Knospe S; Köhler E; Klöting I
    Exp Clin Endocrinol; 1987 Aug; 89(3):290-6. PubMed ID: 3311775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
    Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of anti-islet ADCC after manifestation of type-1 (insulin-dependent) diabetes.
    Köhler E; Knospe S; Besch W; Michaelis D; Rjasanowski I
    Exp Clin Endocrinol; 1989; 94(3):357-62. PubMed ID: 2698355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lymphocytes and serum from probands before and after manifestation of type 1 (insulin-dependent) diabetes on rat islets in vitro.
    Köhler E; Knospe S; Rjasanowski I; Michaelis D
    Exp Clin Endocrinol; 1988 Dec; 92(2):182-8. PubMed ID: 3072214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
    Sobel DO; Creswell K
    Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune reactions against rat pancreatic islets mediated by antibodies from type I diabetic patients.
    Kruschel B; Jahr H; Marx S; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):635-9. PubMed ID: 6383367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific immunotherapy in insulin-dependent diabetes mellitus (preliminary report).
    Lohmann D; Bierwolf B; Krug J; Lampeter E; Verlohren HJ
    Exp Clin Endocrinol; 1986 Aug; 87(3):333-6. PubMed ID: 3536537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-mediated cytotoxic effects of islet cell surface antibodies: factors influencing the sensitivity of the target cells.
    Jahr H; Kruschel B; Walter BM; Kohnert KD
    Biomed Biochim Acta; 1984; 43(5):641-6. PubMed ID: 6383368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
    Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
    Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-cell secretory function and CD25 + lymphocyte subsets in the early stage of type 1 diabetes mellitus.
    Milicevic Z; Knezevic J; Sabioncello A; Roglic G; Rocic B
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):181-6. PubMed ID: 15127321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine profile in children during the first 3 months after the diagnosis of type 1 diabetes.
    Karlsson Faresjö MG; Ernerudh J; Ludvigsson J
    Scand J Immunol; 2004 May; 59(5):517-26. PubMed ID: 15140063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the pathogenesis of type 1 (insulin-dependent) diabetes mellitus: facts, areas still under development and new perspectives.
    Bottazzo GF; Bonifacio E; Wagner R; al-Sakkaf L; Dean BM; Mirakian R
    Klin Wochenschr; 1990; 68 Suppl 21():26-37. PubMed ID: 2198388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of strong association between residual human C-peptide secretion and islet cell antibodies, complement-dependent antibody-mediated cytotoxicity, and HLA antigens in newly diagnosed type I diabetics.
    Michaelis D; Rjasanowski I; Hehmke B; Kohnert KD; Hildmann W; Keilacker H; Richter KV
    Biomed Biochim Acta; 1985; 44(1):99-106. PubMed ID: 3888215
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
    Rattarasarn C; Diosdado MA
    Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different percentages of CD8+ lymphocytes in long-term type 1 diabetics with and without residual beta cell function.
    Buschard K; Dejgaard A; Madsbad S; Röpke C
    Diabetes Res; 1989 Nov; 12(3):105-8. PubMed ID: 2699584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.